460 related articles for article (PubMed ID: 22150115)
1. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
2. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
3. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
4. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M
Radiother Oncol; 2006 Mar; 78(3):270-5. PubMed ID: 16564589
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
7. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
8. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
[TBL] [Abstract][Full Text] [Related]
9. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
[TBL] [Abstract][Full Text] [Related]
10. Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial.
Shakam A; Scrimger R; Liu D; Mohamed M; Parliament M; Field GC; El-Gayed A; Cadman P; Jha N; Warkentin H; Skarsgard D; Zhu Q; Ghosh S
Radiother Oncol; 2011 May; 99(2):101-7. PubMed ID: 21621868
[TBL] [Abstract][Full Text] [Related]
11. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
14. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study.
Saibishkumar EP; Jha N; Scrimger RA; MacKenzie MA; Daly H; Field C; Fallone G; Parliament MB
Radiother Oncol; 2007 Oct; 85(1):98-104. PubMed ID: 17923162
[TBL] [Abstract][Full Text] [Related]
15. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
16. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
17. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma.
Daly ME; Lieskovsky Y; Pawlicki T; Yau J; Pinto H; Kaplan M; Fee WE; Koong A; Goffinet DR; Xing L; Le QT
Head Neck; 2007 Mar; 29(3):211-20. PubMed ID: 17111429
[TBL] [Abstract][Full Text] [Related]
19. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]